Cas 223911-60-2,(1S,2R,6S)-6-[3-(tert-Butyl-diphenyl-silanyloxy)-benzyl]-1-(4,5-diphenyl-oxazol-2-yl)-cyclohexane-1,2-diol

223911-60-2

Post Buying Request

Basic information

Product Name: (1S,2R,6S)-6-[3-(tert-Butyl-diphenyl-silanyloxy)-benzyl]-1-(4,5-diphenyl-oxazol-2-yl)-cyclohexane-1,2-diol
Synonyms:
CAS NO:223911-60-2
Molecular Formula:
Molecular Weight: 679.931
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (1S,2R,6S)-6-[3-(tert-Butyl-diphenyl-silanyloxy)-benzyl]-1-(4,5-diphenyl-oxazol-2-yl)-cyclohexane-1,2-diol(CAS DataBase Reference)
NIST Chemistry Reference: (1S,2R,6S)-6-[3-(tert-Butyl-diphenyl-silanyloxy)-benzyl]-1-(4,5-diphenyl-oxazol-2-yl)-cyclohexane-1,2-diol(223911-60-2)
EPA Substance Registry System: (1S,2R,6S)-6-[3-(tert-Butyl-diphenyl-silanyloxy)-benzyl]-1-(4,5-diphenyl-oxazol-2-yl)-cyclohexane-1,2-diol(223911-60-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 223911-60-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

223911-60-2 Suppliers

Recommended suppliers

223911-60-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 223911-60-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,9,1 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 223911-60:
(8*2)+(7*2)+(6*3)+(5*9)+(4*1)+(3*1)+(2*6)+(1*0)=112
112 % 10 = 2
So 223911-60-2 is a valid CAS Registry Number.

223911-60-2Upstream product

223911-60-2Downstream Products

223911-60-2Relevant academic research and scientific papers

Metabolism investigation leading to novel drug design: Orally active prostacyclin mimetics. Part 4

Hattori, Kouji,Takamura, Fujiko,Tanaka, Akira,Takasugi, Hisashi,Taniguchi, Kiyoshi,Nishio, Mie,Koyama, Satoshi,Seki, Jiro,Sakane, Kazuo

, p. 3284 - 3287 (2005)

A metabolism study of FR181157 (1) led to the discovery of new oxazole derivatives as active metabolites. The metabolite 6 with an epoxy ring exhibited high anti-aggregative potency with an IC50 of 5.8 nM and potent binding affinity for the human recombinant IP receptor with a Ki value of 6.1 nM and selectivity for human IP receptor over all other members of the human prostanoid receptor family.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 223911-60-2